Source: Clinical Therapeutics. Conference titles: Conference of the European Association for Clinical Pharmacology and Therapeutics (EACPT). Unidades: FMRP, FCFRP
Subjects: FARMACOCINÉTICA, FARMACOLOGIA, CONVULSÕES
ABNT
ANTUNES, Natalícia de Jesus et al. Influence of verapamil on the pharmacokinetics of oxcarbazepine and 10-hydroxycarbazepine enantiomers in healthy volunteers. Clinical Therapeutics. Bridgewater: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 16 nov. 2024. , 2013APA
Antunes, N. de J., Wichert-Ana, L., Coelho, E. B., Pasqua, O. D., Alexandre Júnior, V., Takayanagui, O. M., & Lanchote, V. L. (2013). Influence of verapamil on the pharmacokinetics of oxcarbazepine and 10-hydroxycarbazepine enantiomers in healthy volunteers. Clinical Therapeutics. Bridgewater: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.NLM
Antunes N de J, Wichert-Ana L, Coelho EB, Pasqua OD, Alexandre Júnior V, Takayanagui OM, Lanchote VL. Influence of verapamil on the pharmacokinetics of oxcarbazepine and 10-hydroxycarbazepine enantiomers in healthy volunteers. Clinical Therapeutics. 2013 ; 35( 85): e76.[citado 2024 nov. 16 ]Vancouver
Antunes N de J, Wichert-Ana L, Coelho EB, Pasqua OD, Alexandre Júnior V, Takayanagui OM, Lanchote VL. Influence of verapamil on the pharmacokinetics of oxcarbazepine and 10-hydroxycarbazepine enantiomers in healthy volunteers. Clinical Therapeutics. 2013 ; 35( 85): e76.[citado 2024 nov. 16 ]